NasdaqGM - Delayed Quote USD

ANI Pharmaceuticals, Inc. (ANIP)

64.82 -1.21 (-1.83%)
At close: 4:00 PM EDT
64.82 0.00 (0.00%)
After hours: 4:02 PM EDT
Loading Chart for ANIP
DELL
  • Previous Close 66.03
  • Open 66.20
  • Bid 64.51 x 100
  • Ask 64.83 x 100
  • Day's Range 64.60 - 66.57
  • 52 Week Range 43.32 - 70.81
  • Volume 149,187
  • Avg. Volume 159,413
  • Market Cap (intraday) 1.386B
  • Beta (5Y Monthly) 0.81
  • PE Ratio (TTM) 40.26
  • EPS (TTM) 1.61
  • Earnings Date Aug 7, 2024 - Aug 12, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 81.60

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

www.anipharmaceuticals.com

642

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ANIP

Performance Overview: ANIP

Trailing total returns as of 5/15/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ANIP
17.56%
S&P 500
11.29%

1-Year Return

ANIP
55.56%
S&P 500
28.71%

3-Year Return

ANIP
84.88%
S&P 500
27.18%

5-Year Return

ANIP
7.09%
S&P 500
87.28%

Compare To: ANIP

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ANIP

Valuation Measures

Annual
As of 5/14/2024
  • Market Cap

    1.38B

  • Enterprise Value

    1.46B

  • Trailing P/E

    41.01

  • Forward P/E

    15.58

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.41

  • Price/Book (mrq)

    3.06

  • Enterprise Value/Revenue

    2.81

  • Enterprise Value/EBITDA

    11.50

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.87%

  • Return on Assets (ttm)

    3.91%

  • Return on Equity (ttm)

    8.71%

  • Revenue (ttm)

    517.46M

  • Net Income Avi to Common (ttm)

    30.55M

  • Diluted EPS (ttm)

    1.61

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    238.25M

  • Total Debt/Equity (mrq)

    60.93%

  • Levered Free Cash Flow (ttm)

    79.33M

Research Analysis: ANIP

Company Insights: ANIP

Research Reports: ANIP

People Also Watch